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D
uring the summer of 2007, migratory joint pain de-
veloped in my (E.B.B.) 86-year-old father, previously 
an ironworker, farmer, and World War II veteran. Because 
of occasional tick attachments, a Borrelia burgdorferi 
ELISA was performed; antibodies were not detected, and 
no treatment was instituted. In the fall, subtle memory loss 
developed, and he fell twice a few weeks apart. Dad jok-
ingly blamed the falls and the memory loss on “old timer’s 
disease.” Subsequently, episodes of subtle confusion and 
more frequent memory loss generated family concern as 
to what the future might hold. On December 15, he broke 
his left femur during a fall while climbing 2 stairs to enter 
our home. Despite having successfully climbed those stairs 
thousands of times in the past, he would never climb those 
or any other stairs again.
Retrospectively obvious, a pattern of insidious ill-
ness characterized by joint pain, memory loss, and inco-
ordination, not recognizable by my father or other family 
members, had begun before that summer. Medically stable 
historical problems included coronary artery disease, ath-
erosclerosis, carotid artery occlusion, hypertension, and 
atrial ﬁ  brillation. During the previous year, a normocytic, 
normochromic, nonregenerative anemia persisted. Despite 
normal serum iron, total iron binding capacity, ferritin, and 
vitamin B12 values, anemia was attributed to intestinal 
blood loss. When examined in May 2007, before anesthe-
sia for endoscopy, mood and affect were appropriate, recent 
and remote memory were intact, insight and judgment were 
good. A hiatal hernia, mild antral gastritis, and duodenitis 
were visualized.
Initial Hospitalization
When my father was hospitalized December 15, 2007, 
with a broken femur, a resting pill roll tremor and cogwheel 
rigidity were suggestive of Parkinson disease. Preoperative 
neurologic consultation identiﬁ  ed severe confusion, inatten-
tion, and an inability to answer questions. Short-term mem-
ory and problem-solving abilities were decreased. There 
was mild ptosis of the right eye, normal cranial nerves, 
mild asterixis, and hand weakness. Laboratory abnormali-
ties included anemia, hypercreatinemia, an elevated aspar-
tate aminotransferase level, and hyperglobulinemia. Due to 
the severity of the femoral fracture, the femoral head was 
excised and replaced with a bipolar femoral prosthesis.
Postoperatively, poor mentation was considered a se-
quela of general anesthesia and peri-operative analgesics. 
For more than a week, dementia persisted. He did not rec-
ognize family members and had near constant hallucino-
genic activities, including agitation, tying knots, sawing 
motions, and constantly pulling covers, bed clothes, and 
ﬂ  uid lines. Severe hematuria developed after he pulled an 
inﬂ  ated Foley catheter from his urethra. Concurrent gas-
trointestinal bleeding of undetermined cause necessitated 
multiple blood transfusions. Other complications included 
difﬁ  culty swallowing and paralytic ileus. Repeat abdomi-
nal radiographs, in conjunction with stool softeners and 
laxatives, failed to alleviate gastrointestinal complications. 
Eventually, he refused food and became severely bloated. 
Endoscopy performed on December 26 identiﬁ  ed severe 
necrotizing esophagitis, multiple plaques, and a stricture 
attributed to Candida albicans and herpes zoster. C. albi-
cans esophagitis is known to accompany HIV infection, 
leukemia, or an unidentiﬁ  ed source of immune suppres-
sion (1,2). Shingles, caused by herpes zoster, occurred dur-
ing the previous Thanksgiving and can be associated with 
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immunosuppression, stress, or an aging immune system 
(3,4). Mentation and gastrointestinal abnormalities im-
proved after starting treatment with ﬂ  uconazole, acyclo-
vir, and symptomatic medications for erosive esophagitis. 
However, confusion, lack of orientation, hyponatremia, hy-
pokalemia, and hyperglycemia remained problematic until 
discharge to a physical therapy center on December 31.
Second Hospitalization
During the next week, strength and mental capacities 
improved rapidly and discharge to the home environment 
was scheduled for January 9. On that morning and while 
driving to Maryland to build entry ramps, I was informed 
by cell phone that my father fell out of a chair and became 
nonverbal and that a stroke was suspected. For me, the 
roller coaster illness ultimately leading to his death would 
take an unbelievable turn of events. Upon his transfer to 
the neurology service, encephalopathy, asterixis, Parkinso-
nian-type tremor, hypoactive reﬂ  exes, pinpoint and mini-
mally reactive pupils, and cogwheel rigidity were found. 
Verbal communication was absent, but he would grimace 
with pain whenever extremities were manipulated. An ur-
gent computed tomography scan did not identify intracra-
nial abnormalities.
When I was a boy, my father used the expression 
“something is ﬁ  shy in Denmark” to imply that something 
was astray. Based upon historical events, I suspected some-
thing was being missed. Laboratory ﬁ  ndings  included 
anemia (hemocrit 34%), a normal leukogram (leukocytes 
9,100 cells/μL, 2% band neutrophils), mild hypokalemia, 
hypoalbuminemia, hyperglycemia, increased serum alka-
line phosphatase level, erythrocyte sedimentation rate of 
79, and hypergammaglobulinemia. Thoracic radiographs 
identiﬁ  ed mild bilateral pleural effusion. Because an un-
deﬁ  ned infectious source of immunosuppression seemed 
plausible, and fever (maximum temperature 38.6°C) oc-
curred 24 hours after neurologic decompensation an in-
fectious etiology was pursued. Nasal methicillin-resistant 
Staphylococcus aureus, blood, urine, and cerebrospinal 
ﬂ  uid (CSF) cultures were negative. CSF results, including 
those for special stains, were unremarkable. Serologic re-
sults for Treponema pallidum, Borrelia burgdorferi, Rick-
ettsia rickettsii, Bartonella henselae, Bartonella quintana, 
and HIV were negative. Results of CSF herpes simplex 
PCR and a test for T. pallidum antibodies were negative. 
On January 11, results of magnetic resonance imaging 
and magnetic resonance angiography were interpreted as a 
left posterior stroke with no active bleeding. Initial treat-
ment included intravenous acyclovir, ﬂ  uconazole, vanco-
mycin, ceftriaxone, ampicillin, and dexamethasone.
Translational Research and the 
Practice of Medicine
Because I direct the Intracellular Pathogens Research 
Laboratory (IPRL) at the North Carolina State Univer-
sity College of Veterinary Medicine, aseptically obtained 
blood and CSF samples were kindly provided for testing. 
Results of PCR (5,6) speciﬁ  c for Anaplasma, Ehrlichia, 
and Rickettsia species were negative. Bartonella 16S–23S 
intergenic spacer primers (7) repeatedly generated ampli-
cons of different sizes from blood and CSF, respectively. 
Compared with GenBank sequences, the blood amplicon 
was most similar (434/465bp) to Candidatus Bartonella 
volans (strain FSq-1, EU294521) isolated from a south-
ern ﬂ  ying squirrel (Glaucomys volans) and Candidatus 
Bartonella durdenii (391/422bp) ampliﬁ  ed from Orcho-
peas howardi (GenBank accession no. DQ 336386), a ﬂ  ea 
found on eastern US gray squirrels (Scinrus carolinensis), 
and a Bartonella sp. (446/492bp, EF125214) identiﬁ  ed in 
ground squirrels (Spermophilus danricus) in the People’s 
Republic of China. The novel rodent Bartonella sequence 
obtained from my father’s blood had an 18-bp insert at 
positions 2047 or 334 in EU294521 and DQ336386, re-
spectively. Previously, our laboratory had never worked 
with rodent Bartonella species and had never ampliﬁ  ed a 
300-bp internal transcribed spacer region amplicon from 
>3,000 animal or human blood samples. After several un-
successful cloning attempts, the CSF amplicon was most 
similar (393/394 bp) to B. henselae (NC-005956). Blood 
and CSF, cultured by using Bartonella  α Proteobacte-
ria growth medium (BAPGM) (8), did not result in the 
growth of a Bartonella species.
Clinicians and Scientists Working Together
After Bartonella PCR results became available, treat-
ment with piperacillin and tazobactam were continued for 
3 weeks, until discharge. Levetiracetam was added to the 
patient’s treatment because a generalized seizure occurred 
shortly after antimicrobial drugs were given. On January 
18, severe dependent edema of the right elbow resulted 
in ﬂ  uid leakage through intact skin. For 3 weeks, Dad re-
mained semicomatose, disoriented, agitated, and enceph-
alopathic. Hallucinations continued, accompanied by fre-
quent involuntary motor movements. Diabetes mellitus and 
a large decubital ulcer on the right heel developed. During 
the fourth week, mentation improved, and he could rise and 
stand for brief periods. On January 28, he was discharged 
to a rehabilitation facility, with instructions to receive 
doxycycline and rifampin 2×/d for 13 days. Blood samples, 
obtained aseptically before discharge, were again submit-
ted to the IPRL. After BAPGM pre-enrichment and subcul-
ture, B. vinsonii subsp. berkhofﬁ  i genotype II was isolated, 
and sequential serologic testing identiﬁ  ed a rising titer to 
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B. vinsonii subsp. berkhofﬁ  i but did not detect B. henselae 
antibodies (Table). After a brief, emotionally traumatic stay 
at the rehabilitation facility, Dad returned home to be cared 
for by 4 sons, his wife of 60 years, and other family mem-
bers. Each week a different son slept by his bed, which was 
relocated to the family living room.
Home Again at Last
During the next 3 weeks, there was substantial and pro-
gressive improvement in physical capabilities and a return 
of normal mental capabilities, including exceptional short- 
and long-term memory. Appetite normalized, and despite 
severe atrophy, muscle strength increased so he could stand, 
walk with assistance, and, although a daily struggle, access 
the bathroom. A February 10 blood sample obtained while 
he was receiving oral antimicrobial drugs was Bartonella 
PCR negative, and no bacteria were isolated in BAPGM. 
During this precious 3 weeks, our father joked, laughed, 
and vividly recalled wartime friends and other experiences. 
On March 1, 2008, he opened Christmas presents with our 
family. I should have been there.
Third and Final Hospitalization
On March 4, ≈2 weeks after the course of oral antibi-
otics was completed, agitation and disorientation returned, 
and mental status deteriorated. Within 24 hours, Dad was 
hospitalized, where ﬁ  ne motor tremors of the right hand 
and wrist, asymmetric edema involving the right leg, and 
edema of the penis and scrotum were noted. He was afebrile 
and nonverbal and could not follow simple commands. He-
matocrit was 30.2%, platelet count 557,000 cells/μL, and 
leukocyte count 7,800 cells/μL with a normal differential 
count. Serum biochemical abnormalities included hyper-
glycemia (glucose 218 mg/dL), hyperglobulinemia (3.6 
g/dL), and increased alkaline phosphatase activity (169 
IU/L). Urinalysis abnormalities included proteinuria with 
occasional hyaline casts. 
Lorazepam was administered to control the agitation 
and restlessness. The warfarin dose was increased and 
heparinization initiated for a potential cerebrovascular 
accident. Due to the prior documentation of Bartonella 
infection, intravenous doxycycline, rifampin, and gen-
tamicin were administered, and total parenteral nutrition 
was instituted. Again, shortly after initiation of antimi-
crobial drugs, a seizure occurred. Bartonella spp. were 
not ampliﬁ  ed or isolated from a 1-mL blood sample ob-
tained 4 days after initiation of treatment with antimicro-
bial drugs. During the next 3 weeks, while intravenous 
antimicrobial drugs were administered, our father again 
remained encephalopathic, with frequent hallucinations, 
severe agitation, and near-constant mental confusion. On 
March 14, intravenous methylprednisolone for potential 
immune-mediated vasculitis elicited no improvement in 
mental status. Similar to the previous treatment course, 
improvement in mental status, coherent communication, 
and renewed ability to recognize family members oc-
curred during the fourth hospitalization week.
A Battle Lost
On April 4, Dad was discharged to our home and oral 
antimicrobial drugs (doxycycline and rifampin) were dis-
pensed. Despite all efforts by medical professionals, mem-
bers of our family, and our tough 86-year-old father, pro-
tracted illness and prolonged hospitalizations had resulted 
in mental and physical debilitation, severe muscle wasting, 
and profound weakness. More important, he had lost his 
desire to live. After discharge, there was minimal neuro-
logic improvement. Before the  availability of April 4 IPRL 
test results, he began to refuse all medications. The identi-
cal rodent Bartonella DNA sequence was again ampliﬁ  ed 
from his blood, but no bacteria were isolated. 
Four weeks later my father died, on Friday, May 2, 
at 5 PM, around quitting time for an old iron worker. My 
mother and youngest brother were at his side. After his 
Table. PCR, blood, and CSF Bartonella spp. culture and serologic results from an 86-year-old man with recent onset arthritis, memory 
loss, and encephalopathy* 
Serologic results (titers)  BAPGM enrichment platform 
Date Location and sample type 
B.
henselae
B. vinsonii subsp. 





2005 Sep 23  Home/blood NA NA Neg Neg NIO
2006 Aug 19  Home/blood NA NA Neg Neg NIO
2008 Jan 11  Hospital 2/blood  NA NA B. volans–like Neg NIO
Hospital 2/CSF NT NT B. henselae Neg NIO
2008 Jan 28  Hospital 2/EDTA blood  16 16 Neg Neg Bvb II 
Hospital 2/ACD blood  NA NA Neg Neg Bvb II 
2008 Feb 10  Home/blood <16 128 Neg Neg NIO
2008 Mar 11  Hospital 3/blood  <16 64 Neg Neg NIO
2008 Apr 4  Hospital 3/blood  <16 32 B. volans–like Neg Neg
2008 Apr 28  Home/blood 16 64 Neg Bvb II  Neg
*CSF, cerebrospinal fluid; BAPGM, Bartonella Į Proteobacteria growth medium; NA, no available serum; Neg, DNA was not amplified by using Bartonella
16S–23S intergenic spacer primers; NIO, no isolate obtained by subculture after BAPGM pre-enrichment culture; Hospital 2, second hospitalization; NT, 
not tested; ACD, acid-citrate-dextrose; BvbII, B. vinsonii subsp. berkhoffii genotype II; Hospital 3, third hospitalization.   Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009  2083 
death, blood culture results from another sample obtained 
by the hospice nurse on April 28, 2008, became available. 
B. vinsonii subsp. berkhofﬁ  i genotype II was ampliﬁ  ed and 
sequenced from the enrichment BAPGM blood culture. As 
direct extraction of DNA from blood was negative, growth 
of viable bacteria in liquid culture was implicated (8,9).
Groundhogs, Fleas, and the Genus Bartonella
Following our father’s death, I recalled a small, 0.5-cm, 
raised, ﬁ  rm lesion within his right eyebrow that developed 
during the summer of 2007 and would spontaneously hurt 
or burn, causing him to rub or squeeze the lesion. The mass 
disappeared after he began taking antimicrobial drugs in 
2008. Retrospectively, I suspected a rodent ﬂ  ea bite above 
the eye had transmitted a novel Bartonella species, which 
we sequenced from his blood after each hospitalization. 
All known Bartonella spp. have preferential animal reser-
voir hosts, and each uses arthropods or animal bites and 
scratches as the primary modes of transmission (10–12). 
Dad would occasionally capture mice, rats, skunks, and 
groundhogs in the barns. Groundhogs were transported in 
the car trunk to a distant location for release, potentially 
leaving behind ﬂ  eas. Therefore, 3 Candidatus Bartonella 
spp. isolates were provided by Dr. William Nicholson, a 
colleague at the Centers for Disease Control and Preven-
tion in Atlanta. After sequencing, the 16S–23S intergenic 
spacer region of a ground squirrel (Candidatus Bartonella 
durdenii), a ﬂ  ying squirrel (Candidatus Bartonella volans), 
and a groundhog (Candidatus Bartonella monaxi) isolate, 
the most similar GenBank sequence was Candidatus Bar-
tonella volans. There was no perfect match with these 3 iso-
lates. However, sequences from Dad’s blood clustered with 
a squirrel Bartonella subgroup. This observation supports 
the presence of a novel Bartonella species on the eastern 
shore of Maryland, an as yet undeﬁ  ned animal reservoir, 
and an unknown arthropod vector.
Regardless of the mode(s) of transmission, repeated 
molecular documentation of a novel rodent Bartonella sp. 
and B. vinsonii subsp. berkhofﬁ  i supports the unexpected 
failure of 2 intensive courses of intravenous and oral anti-
microbial drugs to eliminate these fastidious, intravascular 
bacteria. During the ﬁ  rst two hospitalization periods, there 
was similar and progressive improvement in neurologic 
signs and mental capabilities that began during the fourth 
week of antimicrobial drug administration. Pre-enrichment 
BAPGM growth of B. vinsonii subsp. berkhofﬁ  i from blood 
obtained 4 days before death supports persistence of viable 
organisms. Recently, antimicrobial drug resistance genes 
have been characterized in B. bacilliformis, B. henselae, 
and B. quintana by in vitro serial passage (13–15). Retro-
spectively, the relapse in encephalopathic signs might have 
been avoided if antimicrobial drugs were continued for a 
larger interval after discharge from hospital 2, and blood 
cultures were optimally obtained and sequentially tested to 
conﬁ  rm therapeutic elimination. 
Elimination of Bartonella spp. by antimicrobial drugs 
in immunocompetent patients may be more difﬁ  cult  to 
achieve than is currently appreciated (16). Although co-
infection with B. henselae and B. vinsonii subsp. berk-
hofﬁ  i has been previously reported, DNA of 3 Bartonella 
spp. was detected in our father. Based on repeatable PCR 
testing, a small quantity of B. henselae DNA was in the 
January CSF sample. Because PCR amplicon contamina-
tion was never detected in any negative control, laboratory 
error is considered unlikely. Although the BAPGM enrich-
ment approach has improved molecular detection and iso-
lation of some Bartonella spp. from human patient samples 
(9,16–18), a rodent Bartonella sp. isolate was not obtained. 
Unfortunately, 8 weeks can be required from inoculation of 
BAPGM until a subculture agar plate isolate is character-
ized by DNA sequencing. Therefore, IPRL test results were 
often not available to Dad’s physicians in a timely manner.
Age, Bartonella spp., and Immune Suppression?
Suspicion of an undetermined source of immune sup-
pression and recent tick exposures were primary factors 
motivating testing in the IPRL. Previously, B. vinsonii 
subsp. berkhofﬁ  i was shown to induce immunosuppression 
in experimentally infected dogs (19,20). In retrospect, oc-
cult infection with Bartonella spp. may have contributed 
to shingles at Thanksgiving and necrotizing C. albicans 
esophagitis after hospitalization for the fractured femur. 
Recently, B. quintana lipopolysaccharide was found to have 
antiinﬂ  ammatory properties (21). Immune suppressive fac-
tors may facilitate persistent intravascular Bartonella in-
fection without inducing obvious infection indicators, such 
as fever, tachycardia, leukocytosis, and CSF pleocytosis. 
Fever was documented once and mild neutrophilia for 3 
of 48 blood counts. Thrombocytosis, previously associated 
with B. henselae (22), was documented 14 times.
Ecologic Complexity of Bartonella spp.
Because of my father’s long-standing atherosclerosis 
and because BAPGM will grow a spectrum of seemingly 
difﬁ  cult to isolate bacteria (8,23), pre-enrichment blood 
cultures and Bartonella internal transcribed spacer  region 
PCR had been performed in September 2005 and August 
2006 (Table). Bartonella spp. were not ampliﬁ  ed or iso-
lated, which suggests infection occurred after the summer 
of 2006. Transmission of B. henselae, B. vinsonii subsp. 
berkhofﬁ  i, and B. alsatica can occur as a result of a scratch 
from a cat, a dog, or a wild rabbit, respectively (17,24–26). 
Cats are the primary reservoir for B. henselae, whereas 
dogs and coyotes are the only reported reservoir hosts for 
B. vinsonii subsp. berkhofﬁ  i genotype II in North America 
(27). Recently, B. vinsonii subsp. berkhofﬁ  i genotype II was 
ANOTHER DIMENSION2084  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009
ANOTHER DIMENSION
isolated by BAPGM blood culture from a cat with recur-
rent osteomyelitis (E.B. Breitschwerdt, unpub. data), which 
suggests that a bacteremic cat might facilitate transmission 
of this subspecies. My parents had an old (≈21 years of 
age) exclusively outdoor barn cat that would occasional-
ly scratch. The cat could not be tested because it died in 
2007. B. henselae and B. clarridgeae have been transmit-
ted experimentally by transfusion to cats (24). Because B. 
vinsonii subsp. berkhofﬁ  i seroconversion occurred during 
hospitalization, transfusion-associated transmission is also 
possible. The exact timing and mode of transmission of B. 
henselae, B. vinsonii subsp. berkhofﬁ  i, and the rodent Bar-
tonella sp. to our father cannot be established. However, his 
illness serves to illustrate the medical and ecologic com-
plexity of this genus.
Occult Infection and Chronic Illness
Reconstructing the history of a chronic illness is al-
ways difﬁ  cult and remains an unexacting science due to 
known, unknown, and undetermined factors that inﬂ  uence 
disease expression over time. Experimental studies that 
used rodent models have emphasized the ability of Bar-
tonella spp. to invade erythrocytes and vascular endothe-
lial cells (28). In vitro studies indicate that B. henselae can 
infect macrophages, microgial cells, dendritic cells, and 
CD34+ progenitor cells (29). B. henselae and B. vinsonii 
subsp. berkhofﬁ  i have been ampliﬁ  ed from dog lymph node 
aspiration samples (30). Thus in a given patient, Bartonella 
organisms likely infect a substantial number of cellular 
targets. B. henselae infection induces chronic arthritis in a 
subset of cat scratch disease (CSD) patients, and atypical 
CSD manifestations are more likely to develop in elderly 
patients (31,32). In the context of arthritis, B. henselae and 
B. vinsonii subsp. berkhofﬁ  i were repeatedly isolated from 
joint ﬂ  uid from a dog in which repeated antimicrobial drug 
therapy was not successful (33). Although a spectrum of 
acute and generally self-limiting neurologic manifestations 
have been historically described in CSD patients, B. hense-
lae and B. vinsonii subsp. berkhofﬁ  i were only recently iso-
lated from patients with chronic neurologic and neurocog-
nitive abnormalities (16).
We propose that the initial arthritic signs, short-term 
memory loss, and incoordination were premonitory signs 
of Bartonella spp. infection, and that persistent infection 
contributed to localized edema, nonregenerative anemia, 
thrombocytosis, hyperglobulinemia, and a protracted de-
bilitating illness accompanied by hallucinations, agitation, 
seizures, and death. Agitation, disorientation, and combat-
ive behavior have been reported in association with CSD 
and physicians have implicated Bartonella spp. as con-
tributors to agitation and treatment-resistant depression 
(34,35). Memory loss and a spectrum of neurocognitive 
complaints have also been reported in immunocompetent 
persons infected with B. vinsonii subsp. berkhofﬁ  i and B. 
henselae (9,16,17).
My Father and “One Medicine”
In recent years, there has been renewed interest in the 
concept of “One Medicine” (36). I hope that lessons from 
my father’s death can reinforce the importance of “One 
Medicine.” However, as in the past, rhetoric may not result 
in needed increases in resource allocation to enhance edu-
cational, research, service, and public health capabilities 
of the veterinary profession (37). In the context of vector-
borne infectious diseases, zoonotic diseases, food safety, 
zoologic medicine, and environmental medicine and eco-
system health, to name a few areas, veterinarians continue 
to make major contributions that ensure and enhance the 
daily health of animals and humans. Because of a research 
focus in comparative infectious diseases and knowledge of 
the biologic, immunologic, and pathophysiologic behavior 
of Bartonella spp. in a spectrum of animal species, a vet-
erinary research laboratory was able to assist with the man-
agement of my father’s illness.
As is often true of research at the bedside and the lab-
oratory bench, new lessons and challenges arose from the 
collective efforts of doctors, nurses, veterinarians, research 
scientists, and others attempting to heal my father. I and my 
family remain sincerely grateful to the many doctors, nurses, 
and other caregivers who contributed to the management of 
my father’s surgical and medical problems. Because of the 
severe encephalopathic and combative nature of his behav-
ior, this was frequently not an easy or pleasant task. Dur-
ing his illness, I was struck by several items: 1) most nurses 
are absolutely amazing, caring, and dedicated profession-
als; 2) in human medicine, unlike veterinary medicine, no 
physician claimed or accepted the responsibility to be my 
father’s doctor; and 3) for many reasons, I found the human 
healthcare system to be frayed, if not broken. Whether blame 
lies with the insurance companies, our litigious society, the 
proﬁ  t-based motivations of hospital administration, the in-
creased complexity of medical technology, or the medical 
education of physicians, it really does not matter. As my fa-
ther would say, “It is no way to do business.” I have taught 
internal medicine at a College of Veterinary Medicine for 32 
years. During that time, every sick animal on our medical 
service had at least 2 doctors (1 being a student), who were 
directly responsible for the animal’s care, for frequent com-
munications with the owner, and for communications with 
the referring veterinarian. In our increasingly complex hos-
pital environments, every patient needs a personal advocate 
or designated doctor to represent his or her interests.
Epilogue
Some years ago in a conversation with my mother I 
suggested that the term natural death may well represent an   Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009  2085 
oversimpliﬁ  cation of the processes that end a person’s life. 
My father and our family were substantially affected dur-
ing his illness. Each day, from initial hospitalization until 
his death, there was at least 1 family member at his side. 
In the eyes of family and friends, my father was a great 
man in so many respects. He was a loving husband, a car-
ing father, diligent worker, and a friend and supporter to 
many persons. Potentially, his illness illustrates a complex 
interaction between intravascular Bartonella infection and 
complex disease expression, provides documentation for 
an as yet uncharacterized zoonotic rodent Bartonella sp., 
and offers disconcerting evidence supporting antimicrobial 
drug ineffectiveness and clinical evidence supporting the 
concept that persistent infection with >1 Bartonella spp. 
may lead to immunosuppression and opportunistic infec-
tions with organisms such as herpes zoster and C. albicans. 
As in his life, Dad would want this story to beneﬁ  t others 
after his death. We hope that it does.
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